HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Bowron, A. Articles by Stansbie, D. Search for Related Content PubMed PubMed Citation Articles by Bowron, A. Articles by Stansbie, D. Related Collections General Clinical Chemistry Lipids, Lipoproteins, and Cardiovascular Risk Factors

Blood Spot Homocysteine: A Feasibility and Stability Study

Department of Clinical Biochemistry, Bristol Royal Infirmary, Bristol BS2 8HW, United Kingdom

^aauthor for correspondence: fax 44-117-928-3107, e-mail ann.bowron@ubht.swest.nhs.uk

The first 20% of the full text of this article appears below.

Homocystinuria is an autosomal recessive disorder usually caused by deficiency of cystathionine ß-synthase, leading to grossly increased plasma and urine concentrations of homocysteine. There is considerable evidence that early detection and treatment can prevent the clinical consequences of the enzyme deficiency (1)(2); therefore, screening for the disorder has been advocated (1). Many cases of homocystinuria have secondary hypermethioninemia. Neonatal screening for homocystinuria by measurement of increased methionine concentrations in dried blood spots (DBS) has been performed in some centers but has poor sensitivity. Approximately 20% of cases are missed, partly because of low methionine concentrations in breast milk and some infant formulas (3). The measurement of homocysteine in DBS has not been used as a screen for homocystinuria, partly because of uncertainty about the suitability of DBS samples. Homocysteine concentrations are unstable in whole blood stored at room temperature and increase by 1.0 µmol/L per hour (4). This is attributable to in vitro erythrocyte transmethylation reactions that lead to continuous production and release of homocysteine (5). It is not known whether homocysteine is released from erythrocytes in blood that has been spotted on filter paper and dried, either during the spotting and drying process or during storage at room temperature. A recent report assessed stability in screening cards that were stored at 4 °C, which does not reflect routine practice (6). Another investigated the stability of DBS samples, using whole blood to which large concentrations of aqueous homocysteine calibrator had been added, thus potentially masking any increase in homocysteine attributable to release from erythrocytes (. . . [Full Text of this Article]